GSTT2B

gene
On this page

Also known as GSTT2P

Summary

GSTT2B (glutathione S-transferase theta 2B, HGNC:33437) is a protein-coding gene on chromosome 22q11.23, encoding Glutathione S-transferase theta-2B (P0CG30). Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.

The protein encoded by this gene, glutathione S-transferase (GST) theta 2B (GSTT2B), is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Human GSTs can be divided into five main classes: alpha, mu, pi, theta, and zeta. The theta class includes GSTT1, GSTT2, and GSTT2B. GSTT2 and GSTT2B are nearly identical to each other, and share 55% amino acid identity with GSTT1. All three genes may play a role in human carcinogenesis. The GSTT2B gene is a pseudogene in some populations.

Source: NCBI Gene 653689 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 8 total
  • MANE Select transcript: NM_001080843

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33437
Approved symbolGSTT2B
Nameglutathione S-transferase theta 2B
Location22q11.23
Locus typegene with protein product
StatusApproved
AliasesGSTT2P
Ensembl geneENSG00000133433
Ensembl biotypeprotein_coding
Entrez653689

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 5 protein_coding

ENST00000290765, ENST00000404172, ENST00000895419, ENST00000932445, ENST00000964515

RefSeq mRNA: 2 — MANE Select: NM_001080843 NM_001080843, NM_001363804

CCDS: CCDS33617, CCDS87010

Canonical transcript exons

ENST00000290765 — 5 exons

ExonStartEnd
ENSE000017279992395828523958458
ENSE000017344452395855123958701
ENSE000017496002396029423960381
ENSE000018337252396102023961195
ENSE000018836562395741423957932

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 96.33.

FANTOM5 (CAGE): breadth broad, TPM avg 0.9431 / max 37.6472, expressed in 529 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1913490.9431529

Top tissues by expression

137 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583496.33gold quality
right adrenal gland cortexUBERON:003582794.58gold quality
right adrenal glandUBERON:000123394.03gold quality
adrenal tissueUBERON:001830394.02gold quality
left adrenal glandUBERON:000123493.51gold quality
apex of heartUBERON:000209892.85gold quality
adrenal glandUBERON:000236992.02gold quality
left adrenal gland cortexUBERON:003582591.80gold quality
fundus of stomachUBERON:000116090.92gold quality
right lobe of liverUBERON:000111490.43gold quality
adenohypophysisUBERON:000219689.60gold quality
stromal cell of endometriumCL:000225589.57gold quality
prostate glandUBERON:000236788.91gold quality
pituitary glandUBERON:000000788.78gold quality
left coronary arteryUBERON:000162688.48gold quality
right frontal lobeUBERON:000281088.26gold quality
right atrium auricular regionUBERON:000663188.12gold quality
right ovaryUBERON:000211888.06gold quality
left ovaryUBERON:000211987.87gold quality
hypothalamusUBERON:000189887.86gold quality
body of stomachUBERON:000116187.81gold quality
amygdalaUBERON:000187687.76gold quality
temporal lobeUBERON:000187187.70gold quality
primary visual cortexUBERON:000243687.67gold quality
anterior cingulate cortexUBERON:000983587.63gold quality
dorsolateral prefrontal cortexUBERON:000983487.60gold quality
body of pancreasUBERON:000115087.54gold quality
esophagogastric junction muscularis propriaUBERON:003584187.38gold quality
ascending aortaUBERON:000149687.25gold quality
right lobe of thyroid glandUBERON:000111987.21gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.12

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

32 targeting GSTT2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-25-3P99.9874.601817
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-57799.7869.132479
HSA-MIR-465899.7764.94514
HSA-MIR-6790-5P99.7765.24505
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-430699.7270.503630
HSA-MIR-365999.7067.97694
HSA-MIR-26A-1-3P99.6466.81788
HSA-MIR-26A-2-3P99.6466.82786
HSA-MIR-315399.5567.592337
HSA-MIR-468899.4864.68828
HSA-MIR-6743-5P99.4863.60721
HSA-MIR-185-5P99.3568.602497
HSA-MIR-464499.3569.122514
HSA-MIR-4652-3P99.3370.022742
HSA-MIR-194-5P99.0169.651465
HSA-MIR-520G-3P98.9167.381914
HSA-MIR-520H98.9167.381914
HSA-MIR-6804-3P98.7264.82852
HSA-MIR-3135B98.6165.331470
HSA-MIR-6731-3P98.6167.86749
HSA-MIR-6873-5P98.4566.141417
HSA-MIR-4778-5P97.9668.061634
HSA-MIR-10526-3P97.8664.971342
HSA-MIR-22-5P97.6768.921355
HSA-MIR-192-3P97.5267.661001
HSA-MIR-320E97.4965.96865
HSA-MIR-313996.6866.77652
HSA-MIR-28-5P96.1666.12579

Literature-anchored findings (GeneRIF, showing 4)

  • study describes a previously uncharacterized 38-kilo-base (kb) long deletion polymorphism of GSTT2B located within a 61-kb DNA inverted repeat (PMID:19424424)
  • results suggest that the presence of the recently described GSTT2B deletion may have a protective effect on the risk of OSCC in the Mixed Ancestry South African population (PMID:22216261)
  • Results GSTT2B insertion allele was associated with an increased risk of being small for gestational age indicate that (PMID:22676722)
  • The data highlights that GSTT2B copy number variant is not associated with the investigated complex diseases in Italian patients. (PMID:26207597)

Cross-species orthologs

42 orthologs

OrganismSymbolGene ID
danio_reriogstrENSDARG00000042620
danio_reriogstt2ENSDARG00000095464
mus_musculusGstt2ENSMUSG00000033318
rattus_norvegicusGstt2ENSRNOG00000052415
drosophila_melanogasterGstD1FBGN0001149
drosophila_melanogasterGstD2FBGN0010038
drosophila_melanogasterGstD3FBGN0010039
drosophila_melanogasterGstD4FBGN0010040
drosophila_melanogasterGstD5FBGN0010041
drosophila_melanogasterGstD6FBGN0010042
drosophila_melanogasterGstD7FBGN0010043
drosophila_melanogasterGstD8FBGN0010044
drosophila_melanogasterGstE12FBGN0027590
drosophila_melanogasterClicFBGN0030529
drosophila_melanogasterGstT3FBGN0031117
drosophila_melanogasterGstE13FBGN0033381
drosophila_melanogasterGstE1FBGN0034335
drosophila_melanogasterGstE11FBGN0034354
drosophila_melanogasterGstO3FBGN0035904
drosophila_melanogasterGstO2FBGN0035906
drosophila_melanogasterGstO1FBGN0035907
drosophila_melanogasterGstD9FBGN0038020
drosophila_melanogasterGstD10FBGN0042206
drosophila_melanogasterGstT1FBGN0050000
drosophila_melanogasterGstT2FBGN0050005
drosophila_melanogasterGstE9FBGN0063491
drosophila_melanogasterGstE8FBGN0063492
drosophila_melanogasterGstE7FBGN0063493
drosophila_melanogasterGstE6FBGN0063494
drosophila_melanogasterGstE5FBGN0063495
drosophila_melanogasterGstE4FBGN0063496
drosophila_melanogasterGstE3FBGN0063497
drosophila_melanogasterGstE2FBGN0063498
drosophila_melanogasterGstE10FBGN0063499
drosophila_melanogasterseFBGN0086348
caenorhabditis_elegansexc-4WBGENE00001365
caenorhabditis_elegansWBGENE00001371
caenorhabditis_elegansgst-43WBGENE00001791
caenorhabditis_elegansWBGENE00001792
caenorhabditis_elegansWBGENE00015337
caenorhabditis_elegansWBGENE00021817
caenorhabditis_elegansWBGENE00043097

Paralogs (14): GSTO2 (ENSG00000065621), GSTT2 (ENSG00000099984), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTO1 (ENSG00000148834), CLIC2 (ENSG00000155962), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)

Protein

Protein identifiers

Glutathione S-transferase theta-2BP0CG30 (reviewed: P0CG30)

Alternative names: Glutathione S-transferase theta-2

All UniProt accessions (3): P0CG30, G9J6Q5, Q6ICJ4

UniProt curated annotations — full annotation on UniProt →

Function. Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Has a sulfatase activity.

Subunit / interactions. Homodimer.

Subcellular location. Cytoplasm. Cytosol.

Tissue specificity. Expressed at low levels in liver. In lung, expressed at low levels in ciliated bronchiolar cells, alveolar macrophages and alveolar type II cells.

Similarity. Belongs to the GST superfamily. Theta family.

RefSeq proteins (2): NP_001074312, NP_001350733 (=MANE)

Domains & families (InterPro)

IDNameType
IPR004045Glutathione_S-Trfase_NDomain
IPR004046GST_CDomain
IPR010987Glutathione-S-Trfase_C-likeDomain
IPR036249Thioredoxin-like_sfHomologous_superfamily
IPR036282Glutathione-S-Trfase_C_sfHomologous_superfamily
IPR040075GST_N_ThetaDomain
IPR040077GST_C_ThetaDomain
IPR040079Glutathione_S-TrfaseFamily
IPR051369GST_ThetaFamily

Pfam: PF00043, PF02798

Enzyme classification (BRENDA):

  • EC 2.5.1.18 — glutathione transferase (BRENDA: 178 organisms, 548 substrates, 680 inhibitors, 878 Km, 525 kcat entries)

Substrate kinetics (BRENDA)

79 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
1-CHLORO-2,4-DINITROBENZENE0.0003–223.6289
GLUTATHIONE0.0002–532.43253
GSH0.0003–37.462
REDUCED GLUTATHIONE0.017–11.424
ETHACRYNIC ACID0.0001–2.4319
CUMENE HYDROPEROXIDE0.038–14.310
(+)-2-BROMO-3-(4-NITROPHENYL)PROPANOIC ACID0.023–0.4178
MONOCHLOROBIMANE0.004–0.258
4-CHLORO-7-NITROBENZO-2-OXA-1,3-DIAZOLE0.324–3.8667
1-IODOHEXANE0.009–0.0596
ALACHLOR0.042–7.236
PHENETHYL ISOTHIOCYANATE0.0065–0.146
STYRENE 7,8-OXIDE0.064–0.3656
1,2-DICHLORO-4-NITROBENZENE0.27–1.45
1-CHLORO-2,3-DINITROBENZOATE0.21–20.75

Catalyzed reactions (Rhea), 1 shown:

  • RX + glutathione = an S-substituted glutathione + a halide anion + H(+) (RHEA:16437)

UniProt features (34 total): helix 13, strand 6, turn 4, binding site 4, sequence conflict 2, domain 2, initiator methionine 1, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

4 structures.

PDBMethodResolution (Å)
4MPGX-RAY DIFFRACTION1.95
1LJRX-RAY DIFFRACTION3.2
2LJRX-RAY DIFFRACTION3.2
3LJRX-RAY DIFFRACTION3.3

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CG30-F198.160.99

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 40–41; 53–54; 66–67; 104–107

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-156590Glutathione conjugation

MSigDB gene sets: 25 (showing top): REACTOME_BIOLOGICAL_OXIDATIONS, GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY, GOBP_AMIDE_METABOLIC_PROCESS, REACTOME_GLUTATHIONE_CONJUGATION, GOBP_GLUTATHIONE_METABOLIC_PROCESS, GOBP_MODIFIED_AMINO_ACID_METABOLIC_PROCESS, REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS, MIR4306, MIR6739_5P, MIR6733_5P, MIR3153, MIR4778_5P, MIR520G_3P_MIR520H, MIR6873_5P, MIR4688

GO Biological Process (1): glutathione metabolic process (GO:0006749)

GO Molecular Function (3): glutathione transferase activity (GO:0004364), protein binding (GO:0005515), transferase activity (GO:0016740)

GO Cellular Component (3): cytoplasm (GO:0005737), cytosol (GO:0005829), extracellular exosome (GO:0070062)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Phase II - Conjugation of compounds1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
modified amino acid metabolic process1
sulfur compound metabolic process1
transferase activity, transferring alkyl or aryl (other than methyl) groups1
binding1
catalytic activity1
intracellular anatomical structure1
cytoplasm1
extracellular vesicle1

Protein interactions and networks

STRING

2103 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GSTT2BHPGDSO60760888
GSTT2BGSTP1P09211791
GSTT2BFBLN1P23142772
GSTT2BGSTM1P09488770
GSTT2BGSTK1Q9Y2Q3747
GSTT2BGSTO2Q9H4Y5741
GSTT2BGSTO1P78417670
GSTT2BGSTM2P28161669
GSTT2BGSTA4O15217652
GSTT2BGSTM3P21266649
GSTT2BGSTM4Q03013643
GSTT2BSLCO6A1Q86UG4643
GSTT2BGSTA1P08263631
GSTT2BGSTZ1O43708630
GSTT2BGSTM5P46439622

IntAct

8 interactions, top by confidence:

ABTypeScore
CFTRGSTT2Bpsi-mi:“MI:0915”(physical association)0.510
GSTT2BSIRT2psi-mi:“MI:0914”(association)0.350
GSTT1ENSApsi-mi:“MI:0914”(association)0.350

BioGRID (21): GSTP1 (Co-fractionation), GSTP1 (Co-fractionation), GSTT2 (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), NMD3 (Affinity Capture-MS), CARD9 (Affinity Capture-MS), SIRT2 (Affinity Capture-MS), GSTT2B (Affinity Capture-MS), MOCS2 (Affinity Capture-MS), GSTT2 (Affinity Capture-MS), SPDL1 (Affinity Capture-MS), NMD3 (Affinity Capture-MS), CARD9 (Affinity Capture-MS), SIRT2 (Affinity Capture-MS), NFRKB (Co-fractionation)

ESM2 similar proteins: A0A1W2PR19, A6QQZ0, O09131, O65857, O76483, O88741, P09488, P0CG29, P0CG30, P21266, P28161, P28342, P30109, P30568, P30713, P42760, P46409, P46430, P46439, P46440, P48774, P57108, P78417, Q01579, Q03013, Q03425, Q03662, Q4V8E6, Q5BK56, Q5R8E8, Q61133, Q64471, Q84TK0, Q8R5I6, Q8TB36, Q9BEA9, Q9BEB0, Q9C6C8, Q9D4P7, Q9FE46

Diamond homologs: A0A1U8QXK4, A0A6J4B5J2, A2Q127, C8VQ63, P0CG29, P0CG30, P12261, P26641, P26642, P29547, P29694, P36008, P40921, P42936, Q00717, Q29387, Q3SZV3, Q4R7H5, Q4WB03, Q5Z627, Q68FR6, Q6PE25, Q6YW46, Q90YC0, Q9D8N0, Q9FUM1, Q9VG98, Q9ZRI7, S0EHD0, W7MMJ0, A0A1W2PR19, O76483, O77473, P20135, P30711, P30713, P46430, P57108, Q01579, Q03425

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

8 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance6
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1066 predictions. Top by Δscore:

VariantEffectΔscore
22:23957753:AG:Adonor_gain1.0000
22:23957929:CCGG:Cacceptor_gain1.0000
22:23957930:CGGC:Cacceptor_gain1.0000
22:23958454:AACAC:Aacceptor_gain1.0000
22:23958455:ACAC:Aacceptor_gain1.0000
22:23958456:CAC:Cacceptor_gain1.0000
22:23958456:CACC:Cacceptor_gain1.0000
22:23958457:ACC:Aacceptor_loss1.0000
22:23958458:CCT:Cacceptor_loss1.0000
22:23958459:C:CCacceptor_gain1.0000
22:23958459:CTGAT:Cacceptor_loss1.0000
22:23958460:T:Cacceptor_loss1.0000
22:23958462:A:ACacceptor_gain1.0000
22:23958547:TCAC:Tdonor_loss1.0000
22:23958548:CACCT:Cdonor_loss1.0000
22:23958697:CCGAG:Cacceptor_gain1.0000
22:23958698:CGAG:Cacceptor_gain1.0000
22:23958698:CGAGC:Cacceptor_gain1.0000
22:23958700:AG:Aacceptor_gain1.0000
22:23958700:AGCT:Aacceptor_loss1.0000
22:23958702:C:CAacceptor_loss1.0000
22:23958702:C:CCacceptor_gain1.0000
22:23958872:T:TAdonor_gain1.0000
22:23960318:T:Adonor_gain1.0000
22:23960377:CTGCC:Cacceptor_gain1.0000
22:23960378:TGCC:Tacceptor_gain1.0000
22:23960380:CC:Cacceptor_gain1.0000
22:23960381:CC:Cacceptor_gain1.0000
22:23960382:C:CCacceptor_gain1.0000
22:23961015:CCCA:Cdonor_loss1.0000

AlphaMissense

1574 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:23958342:G:CF156L0.978
22:23958342:G:TF156L0.978
22:23958344:A:GF156L0.978
22:23961089:G:TR15S0.969
22:23961090:G:CS14R0.963
22:23961090:G:TS14R0.963
22:23961092:T:GS14R0.963
22:23958652:A:GW84R0.961
22:23958652:A:TW84R0.961
22:23958701:G:CS67R0.961
22:23958701:G:TS67R0.961
22:23960295:T:GS67R0.961
22:23960359:G:CF45L0.961
22:23960359:G:TF45L0.961
22:23960361:A:GF45L0.961
22:23958360:G:CF150L0.959
22:23958360:G:TF150L0.959
22:23958362:A:GF150L0.959
22:23961088:C:GR15P0.958
22:23957879:C:AW193C0.948
22:23957879:C:GW193C0.948
22:23957881:A:GW193R0.945
22:23957881:A:TW193R0.945
22:23961070:G:TA21D0.945
22:23960303:A:GL64S0.944
22:23958601:A:GW101R0.943
22:23958601:A:TW101R0.943
22:23958313:T:AD166V0.940
22:23961055:A:GI26T0.939
22:23960347:G:CN49K0.938

dbSNP variants (sampled 300 via entrez): RS1003287663 (22:23958251 G>A), RS1003626883 (22:23957892 C>T), RS1006732496 (22:23959350 C>T), RS1007215800 (22:23959966 C>T), RS1007761328 (22:23957135 C>G), RS1017654543 (22:23958925 T>C), RS1021931656 (22:23958622 G>A,C), RS1026501187 (22:23957663 G>C,T), RS1027636699 (22:23959682 A>G), RS1027708348 (22:23960026 G>A), RS1029936962 (22:23958809 G>C), RS1033793744 (22:23958267 C>A), RS1037866466 (22:23957140 C>G,T), RS1037897466 (22:23958093 G>T), RS1039545819 (22:23959970 TCTC>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001277_19Liver enzyme levels (gamma-glutamyl transferase)2.000000e-09
GCST90011898_167Alanine aminotransferase levels2.000000e-09
GCST90011900_16Serum alkaline phosphatase levels8.000000e-17

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004532serum gamma-glutamyl transferase measurement
EFO:0004533alkaline phosphatase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
(+)-JQ1 compoundincreases expression1
Acetylglucosamineincreases expression1
Ivermectindecreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1increases methylation1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B1TBAbcam HeLa GSTT2B KOCancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.